Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The accelerating need for pharmacovigilance.

I R Edwards1

  • 1Uppsala Monitoring Centre, Sweden. info@who-umc.org

Journal of the Royal College of Physicians of London
|March 16, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adverse drug reaction reporting in Europe: some problems of comparison.

The International journal of risk & safety in medicine·2013
Same author

Correlation between plasma quinidine and cardiac effect.

British journal of clinical pharmacology·2012
Same author

The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database.

Fundamental & clinical pharmacology·2008
Same author

Ingestion of a quadhelix appliance requiring surgical removal: a case report.

Journal of orthodontics·2007
Same author

Data mining in spontaneous reports.

Basic & clinical pharmacology & toxicology·2006
Same author

Introducing triage logic as a new strategy for the detection of signals in the WHO Drug Monitoring Database.

Pharmacoepidemiology and drug safety·2004
Same journal

A Change of Government and Its Effect on the NHS Hospital Outpatient Service.

Journal of the Royal College of Physicians of London·2019
Same journal

Erratum: Model for the Organisation of a Community-Based Rehabilitation Service.

Journal of the Royal College of Physicians of London·2019
Same journal

Telemedicine and beyond.

Journal of the Royal College of Physicians of London·2019
Same journal

Palliative Care in General Medicine.

Journal of the Royal College of Physicians of London·2019
Same journal

Medical Negligence.

Journal of the Royal College of Physicians of London·2019
Same journal

In Response.

Journal of the Royal College of Physicians of London·2019
See all related articles

The pharmaceutical industry faces pressure to rapidly develop blockbuster drugs, potentially overlooking safety issues. Current pharmacovigilance systems may struggle to detect and address drug-related harm effectively.

Area of Science:

  • Pharmacovigilance
  • Drug Development
  • Pharmaceutical Industry Analysis

Background:

  • Increasing scientific knowledge enables complex therapeutic interventions.
  • Commercial pressures drive the pharmaceutical industry towards globally marketed 'blockbuster' drugs.
  • Shortened development timelines and outsourcing raise concerns about unnoticed pre-marketing safety issues.

Purpose of the Study:

  • To examine the evolving challenges in pharmacovigilance.
  • To assess the adequacy of systems for identifying drug benefits and risks.
  • To highlight potential risks of harm from globally marketed drugs.

Main Methods:

  • Literature review on pharmaceutical industry trends.
  • Analysis of pharmacovigilance system capabilities.

Related Experiment Videos

  • Risk-benefit assessment frameworks.

    • Main Results:

    • Drug development is increasingly complex and commercially driven.
    • Industry changes may compromise the detection of pre-marketing safety signals.
    • Existing pharmacovigilance may be insufficient for rapid, accurate benefit-risk determination.

    Conclusions:

    • Enhanced pharmacovigilance is crucial for global drug safety.
    • Systemic improvements are needed to prevent harm from new medicines.
    • The balance between rapid drug approval and thorough safety evaluation requires re-evaluation.